Similar articles

• Vaccine safety perceptions and experience with adverse events following immunization in Kazakhstan and Uzbekistan: a summary of key informant interviews and focus groups.

  Fowler GL, Kennedy A, Leidel L, Kohl KS, Khromava A, Bizhanova G, Shui I, Gust D. Fowler GL, et al. Vaccine. 2007 May 4;25(18):3536-43. doi: 10.1016/j.vaccine.2007.01.082. Epub 2007 Jan 26. Vaccine. 2007. PMID: 17293012
• Adverse events temporally associated with immunizing agents--1988 report.

  Duclos P, McCarthy R, Koch J, Carter A. Duclos P, et al. Can Dis Wkly Rep. 1990 Aug 11;16(32):157-64. Can Dis Wkly Rep. 1990. PMID: 2208346 English, French. No abstract available.
• [Vaccination--rarely complications, but serious enough. Interview by Kjell Arne Bakke].

  Iversen B. Iversen B. Tidsskr Sykepl. 1997 Jul 1;85(12):24-5. Tidsskr Sykepl. 1997. PMID: 9377448 Norwegian. No abstract available.
• Safety monitoring in vaccine development and immunization.

  Lee CJ, Lee LH, Lu CH, Huang YJ, Chu ML. Lee CJ, et al. Acta Paediatr Taiwan. 2006 Jan-Feb;47(1):7-13. Acta Paediatr Taiwan. 2006. PMID: 17016963 Review.
• Addressing immunization barriers, benefits, and risks.

  Kimmel SR, Burns IT, Wolfe RM, Zimmerman RK. Kimmel SR, et al. J Fam Pract. 2007 Feb;56(2 Suppl Vaccines):S61-9. J Fam Pract. 2007. PMID: 17270112 Review.